Description
The Interim Order (IO) No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19 | HTML | Open resource | |
| Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19 | HTML | Open resource |